Biogen Inc. buy Needham & Company LLC
Start price
01.08.24
/
50%
€198.10
Target price
01.08.25
€266.57
Performance (%)
-42.66%
End price
02.08.25
€113.60
Summary
This prediction ended on 02.08.25 with a price of €113.60. The BUY prediction by Needham___Company_LL for Biogen Inc. performed very badly with a performance of -42.66%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 6.848% | 6.848% | 9.570% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $288.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten